Tags: Triple-Drug | Therapy | Reduces | Stroke | Severity

Triple-Drug Therapy Reduces Stroke Severity

Wednesday, 26 April 2006 12:00 AM

When ischemic strokes occur, patients who happen to be taking a combination of ACE inhibitors, antiplatelet agents, and statins wind up with reduced damage, according to a study from Boston's Beth Israel Deaconess Medical Center.

Researchers reviewed the records of 210 patients who arrived at the hospital within 24 hours of having a stroke. Those on the triple therapy wound up having smaller strokes and less permanent damage, shorter length of stay and better functional status on discharge.

In addition, 65 percent of patients who took all three prophylactic agents showed neurologic improvement from admission to discharge while only 33 to 45 percent of the other patients did, depending on which drugs they were taking.

"Our results suggest that pre-stroke use of antiplatelets in combination with statins and angiotensin-converting enzyme inhibitors results in additive reduction in ischemic stroke severity and volume of penumbral brain tissue at risk for infarction," Dr. Magdy Selim and colleagues wrote in their report in the journal, Neurology. In an accompanying editorial, top experts agreed that the triple combination may become the recommended protective drug treatment for patients at high risk for strokes.

110

© 2019 Newsmax. All rights reserved.

   
1Like our page
2Share
Pre-2008
When ischemic strokes occur, patients who happen to be taking a combination of ACE inhibitors, antiplatelet agents, and statins wind up with reduced damage, according to a study from Boston's Beth Israel Deaconess Medical Center. Researchers reviewed the records of 210...
Triple-Drug,Therapy,Reduces,Stroke,Severity
188
2006-00-26
Wednesday, 26 April 2006 12:00 AM
Newsmax Media, Inc.
 

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
America's News Page
© Newsmax Media, Inc.
All Rights Reserved